Ginkgo Bioworks (DNA) Q1 2025 Earnings
Ginkgo Bioworks reported Q1 2025 revenue of $48.3M (+27.3% YoY), beat analyst consensus of $41.6M by $6.7M. Diluted EPS came in at $-1.58 (+50.6% YoY), missed the $-1.23 consensus by $0.35.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Ginkgo Bioworks's Q1 2025 earnings report.
Ginkgo Bioworks (DNA) reported Q1 2025 earnings on May 6, 2025 after market close.
Ginkgo Bioworks reported revenue of $48.3M and diluted EPS of $-1.58 for Q1 2025.
Revenue beat the consensus estimate of $41.6M by $6.7M. EPS missed the consensus estimate of $-1.23 by $0.35.
Compared to the same quarter a year prior, revenue grew 27.3% from $37.9M a year earlier and diluted EPS grew 50.6% from $-3.20.
You can read the 10-Q periodic report (0001628280-25-022761) directly on SEC EDGAR. The filing index links above go to sec.gov.